SARS-CoV-2,广

Alexandra C Walls1, Kaitlin R Sprouse2, John E Bowen2

  • 1Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.

Cell
|February 6, 2022
PubMed
概括

与初始疫苗接种相比,COVID-19突破性感染显著增强了抗体反应,提供了更强效和耐久性. 多次接触SARS-CoV-2抗原可以提高抗体质量,从而获得更好的保护.